Press Goes Global With University Of Minnesota Medical School

By June 5, 2019 January 7th, 2021 No Comments

Major Milestone Reached, As Global Team Of Key Clinical Researchers Publish

MINNEAPOLIS, MN (June 6th, 2019) —, a Minnesota Based healthcare artificial intelligence company, announced a major milestone today, as their landmark healthcare vision becomes a reality. Led by Dr. Kevin Peterson, Professor and Director of the Center of Excellence in Primary Care and’s Medical Director, the creation of an international team of doctors from the University of Minnesota (UMN) Medical School was completed.

This diverse team commenced population of the MERLIN artificial intelligence platform. Following the technical completion of this next generation global platform, clinicians from around the world commenced publishing diagnosis and treatment data and protocols, thereby creating a unique world publishing platform. MERLIN is the first artificial intelligence system to diagnose the probability of disease and recommend treatment in the context of an individual’s medical history. This will provide better, safer, and more comprehensive care direct to consumers and medical professionals, in multiple languages.

According to John Fraser, President and CEO, “We are truly excited to announce this major milestone for our MERLIN artificial intelligence platform, to the world. This milestone is the culmination of many years of cutting-edge technical development using numerous new technologies in healthcare. Our clinical and technical experts are committed to improving healthcare globally. At Treatment, as we populate this global platform, we will truly rewrite textbooks, delivering pragmatic changes to clinical care across the globe. Once comprehensive publishing of diagnoses and treatment plans is completed in the fall of this year, MERLIN has the ability to revolutionize and impact all stakeholders in healthcare, globally.”

Treatment’s MERLIN Artificial intelligence Platform uses age, sex, geo-location, and medical history as background information before beginning an interactive dialog with a user presenting with a medical concern. The system is being developed within the private, secure and scalable Google Cloud Service, using the latest Kubernetes technologies supporting global scalability. Completion of MERLIN training is expected in the fall of 2019, followed by clinical testing using industry-standard research protocols, then commercial release starting in North America.

About Inc is a Minneapolis/Saint Paul and Vancouver, BC based company with a team of experts from around the world. Treatment’s, MERLIN – Enterprise intelligence Platform (EIP) delivers a unique suite of modules serving the consumer, clinical and commercial stakeholders in healthcare. Furthermore, the MERLIN Platform brings forth superiority over conventional artificial intelligence solutions, by delivering hybrid commercial pricing models, challenging traditional care models. Our goal is to change the way health care is delivered, moving it from bricks and mortar to online, from medical textbooks to artificial intelligence.